Kidney News

Kidney News

Practice Pointers

Query and Hypothesis

Is the risk of ODS the same at all levels of starting PNa levels? And if not, perhaps we do not need to re-lower the PNa if starting in the mid-120s?

Policy Update

When Kidney News went to print, the U.S. House of Representatives had passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. Passed with bipartisan support, H.R.

Findings

Kidney function declines twice as rapidly in adults with versus without diabetes, according to a population-based study in Diabetes Care.

Industry Spotlight

The U.S. Food and Drug Administration recently approved Pfizer’s biosimilar anemia drug, Retacrit (epoetin alfa-epbx). After two previous approval attempts, Retacrit was approved as a biosimilar to Epogen (Amgen) and Procrit (epoetin alfa, Johnson & Johnson).

Fellows Corner

Millions of lives have been successfully prolonged through dialysis. However, the world of dialysis has changed since its inception. With time, our patient population has evolved from young and fit to old and sick.

April 2017 Issue

The Senate Committee on Homeland Security and Governmental Affairs is reviewing a report and considering action to modify and expand requirements for federal advisory committees through the Federal Advisory Committee Act Amendments of 2017, H.R. 70.

All Issues

Read past issues of
ASN Kidney News.

Established in 2009, ASN Kidney News has kept the kidney community informed of the latest clinical, scientific, and policy issues affecting kidney health professionals and patients with kidney disease.

Video Library

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics.

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics.

ASN Executive Director Tod Ibrahim discusses a variety of nephrology related topics. The American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.